https://ift.tt/U2aApDw
from Sanofi - Aventis Groupe https://ift.tt/5SB91vO
via IFTTT
from health care https://ift.tt/B7hFnEU
via IFTTT https://ift.tt/CJi79Ba
Home
health issue
ALTUVIIIO™ approved by the U.S. FDA: this positive event triggers impairment reversal, positively impacting 2022 IFRS net income; no change on business net income (non-IFRS)
- Blogger Comment
- Facebook Comment
Subscribe to:
Post Comments
(
Atom
)
0 Comments:
Post a Comment
Please ...
Don't enter span link...